These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30536702)

  • 1. The Evolution of PharmVar.
    Gaedigk A; Sangkuhl K; Whirl-Carrillo M; Twist GP; Klein TE; Miller NA;
    Clin Pharmacol Ther; 2019 Jan; 105(1):29-32. PubMed ID: 30536702
    [No Abstract]   [Full Text] [Related]  

  • 2. The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database.
    Gaedigk A; Ingelman-Sundberg M; Miller NA; Leeder JS; Whirl-Carrillo M; Klein TE;
    Clin Pharmacol Ther; 2018 Mar; 103(3):399-401. PubMed ID: 29134625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoepigenetics: its role in interindividual differences in drug response.
    Gomez A; Ingelman-Sundberg M
    Clin Pharmacol Ther; 2009 Apr; 85(4):426-30. PubMed ID: 19242404
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacogenetics-based new therapeutic concepts.
    Roots I; Gerloff T; Meisel C; Kirchheiner J; Goldammer M; Kaiser R; Laschinski G; Brockmöller J; Cascorbi I; Kleeberg U; Hildebrandt AG
    Drug Metab Rev; 2004 Oct; 36(3-4):617-38. PubMed ID: 15554239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in response to medicines in older people: phenotypic and genotypic factors.
    McLachlan AJ; Hilmer SN; Le Couteur DG
    Clin Pharmacol Ther; 2009 Apr; 85(4):431-3. PubMed ID: 19225449
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method.
    Ozdemir V; Kalow W; Tang BK; Paterson AD; Walker SE; Endrenyi L; Kashuba AD
    Pharmacogenetics; 2000 Jul; 10(5):373-88. PubMed ID: 10898107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying genetic components of drug response in mice.
    Cotsapas C
    Pharmacogenomics; 2008 Sep; 9(9):1323-30. PubMed ID: 18781858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of pharmacoecology: which route to personalized medicine?
    Robertson GR; Grant DM; Piquette-Miller M
    Clin Pharmacol Ther; 2009 Apr; 85(4):343-8. PubMed ID: 19295529
    [No Abstract]   [Full Text] [Related]  

  • 9. Opportunities and obstacles in genotypic prediction of cytochrome P450 phenotypes.
    McGraw J; Gerhardt A; Morris TC
    Expert Opin Drug Metab Toxicol; 2018 Jul; 14(7):659-661. PubMed ID: 29863909
    [No Abstract]   [Full Text] [Related]  

  • 10. Nomenclature of the rat Cyp genes and the problems of gene nomenclature in general [Nelson, D.R. (2005), 'Gene nomenclature by default, or BLASTing to Babel', Hum. Genomics Vol. 2, pp. 196-201].
    Levan G; Jacob HJ
    Hum Genomics; 2006 Jun; 2(6):343; author reply 343-4. PubMed ID: 16848971
    [No Abstract]   [Full Text] [Related]  

  • 11. [The cytochrome P-450 system].
    Spigset O
    Tidsskr Nor Laegeforen; 2001 Nov; 121(28):3296-8. PubMed ID: 11826461
    [No Abstract]   [Full Text] [Related]  

  • 12. Introducing Project Africa GRADIENT.
    Rajman I; Pasqua OD;
    Drug Discov Today; 2019 Dec; 24(12):2229-2230. PubMed ID: 31693869
    [No Abstract]   [Full Text] [Related]  

  • 13. P450 gene nomenclature based on evolution.
    Nebert DW; Nelson DR
    Methods Enzymol; 1991; 206():3-11. PubMed ID: 1784216
    [No Abstract]   [Full Text] [Related]  

  • 14. Mendelian Inheritance in Man and its online version, OMIM.
    McKusick VA
    Am J Hum Genet; 2007 Apr; 80(4):588-604. PubMed ID: 17357067
    [No Abstract]   [Full Text] [Related]  

  • 15. Nomenclature for factors of the HLA system, update March 2011.
    Marsh SG;
    Tissue Antigens; 2011 Jul; 78(1):77-9. PubMed ID: 21658008
    [No Abstract]   [Full Text] [Related]  

  • 16. Lessons from the CYP3A4 promoter.
    Schuetz EG
    Mol Pharmacol; 2004 Feb; 65(2):279-81. PubMed ID: 14742668
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-metabolizing enzymes: evidence for clinical utility of pharmacogenomic tests.
    Andersson T; Flockhart DA; Goldstein DB; Huang SM; Kroetz DL; Milos PM; Ratain MJ; Thummel K
    Clin Pharmacol Ther; 2005 Dec; 78(6):559-81. PubMed ID: 16338273
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytochrome P450 nomenclature.
    Nelson DR
    Methods Mol Biol; 1998; 107():15-24. PubMed ID: 14577209
    [No Abstract]   [Full Text] [Related]  

  • 19. With your genes? Take one of these, three times a day.
    Abbott A
    Nature; 2003 Oct; 425(6960):760-2. PubMed ID: 14574377
    [No Abstract]   [Full Text] [Related]  

  • 20. Human cytochrome P450 (CYP) genes: recommendations for the nomenclature of alleles.
    Ingelman-Sundberg M; Daly AK; Oscarson M; Nebert DW
    Pharmacogenetics; 2000 Feb; 10(1):91-3. PubMed ID: 10739177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.